1. Home
  2. NICE Guidance
  3. Health and social care delivery
  4. Medicines management

Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

NICE guideline [NG5] Published date: March 2015

Uptake of this guidance
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Surveillance report  
  • 2019 surveillance of medicines adherence (NICE guideline CG76) and medicines optimisation (NICE guideline NG5)  
  • Appendix A1: Summary of evidence from surveillance (medicines adherence) PDF 1.13 MB 27 March 2019  
  • Appendix B1: Stakeholder consultation comments table (medicines adherence) PDF 782.22 KB 27 March 2019  
  • Appendix A2: Summary of evidence from surveillance (medicines optimisation) PDF 881.19 KB 27 March 2019  
  • Appendix B2: Stakeholder consultation comments table (medicines optimisation) PDF 659.55 KB 27 March 2019  
  • Full guidance  
  • Appendices PDF 8.41 MB 04 March 2015  
  • Full guideline PDF 2.63 MB 04 March 2015